GEODE CAPITAL MANAGEMENT, LLC
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in CRNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$90,101,311
-$14,293,161 QoQ
Shares Held
2,480,763
+10.6% QoQ
Ownership
2.35%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,556,460,669 across 523 Biotechnology names. CRNX ranks #43 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in CRNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $90,101,311 | 2,480,763 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $104,394,472 | 2,242,631 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $94,913,269 | 2,278,830 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $63,655,226 | 2,213,325 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $73,483,858 | 2,190,932 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $107,313,739 | 2,098,841 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $94,439,595 | 1,848,133 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $75,174,953 | 1,678,387 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $65,599,674 | 1,401,403 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $48,128,069 | 1,352,672 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $37,760,104 | 1,269,674 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $17,794,569 | 987,490 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $15,335,051 | 954,860 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $16,858,509 | 921,230 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $17,343,985 | 883,095 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $15,869,993 | 850,938 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $16,251,450 | 740,385 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $19,851,146 | 698,738 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $10,945,936 | 519,997 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $9,591,275 | 508,821 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,767,191 | 377,434 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,536,379 | 321,501 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,885,545 | 311,777 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,546,130 | 316,560 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,970,079 | 134,019 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||